The group is set to raise gross proceeds amounting to $26.2 million and will have a market capitalisation of $231.8 million upon listing. The proceeds from the invitation shares will provide the group with, among other things, additional capital to finance the acquisition of new equipment and facilities and upgrading of systems, working capital and repayment of bank borrowings.
Singapore Institute of Advanced Medicine Holdings (SAM Holdings), which aims to become a comprehensive one-stop ambulatory cancer centre, has successfully completed the registration of its offer document in connection with its proposed initial public offering (IPO) and listing on the Catalist Board SGX and is now open for subscription by the public.
The group’s IPO entails the issuance of 114.0 million new 23 cents per share by way of public offer and approximately 109.6 million placement shares at an invitation price of 23 cents per share by way of placement.
